|
|
|
Volumn 13, Issue 7, 2001, Pages 27-40
|
|
New treatments of Alzheimer disease: A review
|
|
Author keywords
Alzheimer disease; Cholinesterase inhibitors; Dementia
|
|
Indexed keywords
ACETYLCHOLINESTERASE;
ALPHA TOCOPHEROL;
ANTIINFLAMMATORY AGENT;
ANTIOXIDANT;
CARBAMAZEPINE;
CHOLINESTERASE INHIBITOR;
CIMETIDINE;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
CYTOCHROME P450;
CYTOCHROME P450 2D6;
CYTOCHROME P450 3A4;
DEXAMETHASONE;
DONEPEZIL;
ESTROGEN;
GALANTAMINE;
GINKGO BILOBA EXTRACT;
INDOMETACIN;
MONOAMINE OXIDASE INHIBITOR;
NONSTEROID ANTIINFLAMMATORY AGENT;
PHENYTOIN;
PLACEBO;
RIVASTIGMINE;
SABELUZOLE;
SELEGILINE;
TACRINE;
THEOPHYLLINE;
ALZHEIMER DISEASE;
ANOREXIA;
BEHAVIOR DISORDER;
BRAIN DEGENERATION;
CHOLINERGIC SYSTEM;
CLINICAL TRIAL;
COGNITIVE DEFECT;
DAILY LIFE ACTIVITY;
DEMENTIA;
DIARRHEA;
DIFFERENTIAL DIAGNOSIS;
DISEASE COURSE;
DISEASE SEVERITY;
DOSE RESPONSE;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG METABOLISM;
DRUG SELECTIVITY;
FOOD DRUG INTERACTION;
HEALTH CARE COST;
HUMAN;
INTERVIEW;
LIVER TOXICITY;
MEDICAL ASSESSMENT;
NAUSEA;
NEUROPSYCHOLOGICAL TEST;
PATHOPHYSIOLOGY;
REVIEW;
SIDE EFFECT;
SYMPTOM;
TREATMENT OUTCOME;
UNITED STATES;
VERTIGO;
VOMITING;
|
|
EID: 0034919194
PISSN: 10805826
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (13)
|
|
References (80)
|
